Built from Protagenic Therapeutics, Inc.\new’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$0.740.0%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 6, 2026
Grade F
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 30 quarters of Protagenic Therapeutics, Inc.\new’s grade history. The other 28 go back to April 2017.